IRIS
SACCANI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.143
NA - Nord America 1.095
AS - Asia 489
Continente sconosciuto - Info sul continente non disponibili 5
Totale 2.732
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.081
CN - Cina 413
FI - Finlandia 326
SE - Svezia 278
IE - Irlanda 236
IT - Italia 104
UA - Ucraina 71
DE - Germania 67
TR - Turchia 47
AT - Austria 29
IN - India 15
CA - Canada 14
BE - Belgio 11
SG - Singapore 11
FR - Francia 9
EU - Europa 5
GB - Regno Unito 5
RU - Federazione Russa 2
CH - Svizzera 1
HU - Ungheria 1
IR - Iran 1
JP - Giappone 1
MD - Moldavia 1
NL - Olanda 1
RO - Romania 1
VN - Vietnam 1
Totale 2.732
Salva come PNG Salva come JPEG
Città #
Chandler 277
Dublin 236
Beijing 102
Jacksonville 99
Dearborn 96
Parma 81
Nanjing 65
Ashburn 53
New York 52
Ann Arbor 48
Izmir 44
Princeton 39
Shanghai 36
Vienna 29
Wilmington 24
Boardman 23
Nanchang 23
San Mateo 23
Kunming 20
Hebei 19
Jinan 17
Bremen 16
Des Moines 15
Helsinki 15
Seattle 14
Hefei 13
Guangzhou 12
Brussels 11
Pune 11
Shenyang 11
Toronto 10
Changsha 9
Tianjin 9
Zhengzhou 9
Jiaxing 8
Norwalk 8
Hangzhou 7
Cagliari 4
Chengdu 4
Fremont 4
Woodbridge 4
Augusta 3
Chongqing 3
Fuzhou 3
Grafing 3
Houston 3
Kocaeli 3
Mantova 3
Rockville 3
Taizhou 3
Wenzhou 3
Düsseldorf 2
Gainesville 2
Haikou 2
Lanzhou 2
Manchester 2
Mestre 2
Montreal 2
Montréal 2
Redmond 2
Redwood City 2
Reggio Nell'emilia 2
Xian 2
Alchevs'k 1
Bangalore 1
Baotou 1
Bologna 1
Borås 1
Budapest 1
Cardiff 1
Castel Goffredo 1
Chicago 1
Chisinau 1
Focsani 1
Frankfurt am Main 1
Goose Creek 1
Hanoi 1
Huizen 1
Jamaica Plain 1
Langfang 1
Leawood 1
Los Angeles 1
Modena 1
Montegaldella 1
New Delhi 1
Ningbo 1
Old Bridge 1
Philadelphia 1
Sassuolo 1
Shaoxing 1
Spezzano Albanese 1
Taiyuan 1
Tehran 1
Tokyo 1
Zurich 1
Totale 1.686
Salva come PNG Salva come JPEG
Nome #
Effect of μ Opioid Receptor Activation On Intestinal Ischemia/Reperfusion Injury in Mice 99
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 99
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 92
Targeting PI3K somatic mutations reduces invasion and EMT in squamous cell carcinoma of the lung 91
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 90
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 87
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 86
Gastrointestinal symptoms and local oxidative stress in a model of Parkinson's Disease in rats 85
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification 83
Dual role of endogenous serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-induced colitis 82
Daily assumption of fermented milk containing Bifidobacterium breve 246 B® promotes prophylactic effects against intestinal inflammation in mice 81
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 80
Erlotinib enhances antibody-dependent cellular cytotoxicity of wil-type erlotinib-sensitive NSCLC cell lines 78
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 78
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 77
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines 76
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 75
Analgesic activity of new hybrid muscarinic agonists in mice 74
Effect of specific PI3K/mTOR inhibitors in squamous lung cancer cells carrying PI3K alterations 72
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 72
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 71
Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation. 71
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 71
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 70
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 69
Activation of μ opioid receptors ameliorates mucosal injury induced by intestinal ischemia and reperfusion in mice 65
Radiological analysis of gastrointestinal dysmotility associated with central dopaminergic impairment in an animal model of parkinson's disease (PD) 65
5-HT1A receptors as target to protect the intestine in an experimental model of colitis 65
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 64
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer 63
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 59
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced inflammatory injuries in mice 59
Pharmacological modulation of 5HT1A receptors in mice mesenteric ischemia/reperfusion injury: protective effect of Buspirone and WAY100135 55
Effects of FGFR1 inhibition on survival, proliferation, and energy metabolism in Non Small Cell Lung Cancer (NSCLC) cell lines 55
Protective role of μ opioid receptor activation in intestinal inflammation induced by mesenteric ischemia/reperfusion in mice. 50
T-DM1: a new therapeutic approach in HER-2 overexpressing NSCLC cell lines 44
Pharmacological characterization of a new non-himidazole histamine H3 antagonist 42
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 41
Investigation into the μ opioid receptor role in an experimental model of mesenteric ischemia/reperfusion 39
Totale 2.775
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.067
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.067
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201965 0 0 0 0 0 0 0 0 0 0 56 9
2019/2020585 102 133 28 12 34 65 68 9 39 48 18 29
2020/2021153 1 19 7 1 20 2 20 0 36 14 33 0
2021/2022174 2 0 0 25 6 3 23 21 8 10 9 67
2022/2023984 119 132 62 85 81 113 24 38 271 2 46 11
2023/2024261 15 18 4 12 24 92 32 40 18 6 0 0
Totale 2.775